APO RESEARCH · REPORT
Oligonucleotides
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Product & engineering
Understand the product.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Selected research
Industry Research
Oligonucleotides Industry Research Report 2026
Market perspective
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
Read the full market overview
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
Report Scope
This report quantifies the global Oligonucleotides market in terms of revenue (US$ million) and, where applicable, service volume (Million MT), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Million MT) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oligonucleotides.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oligonucleotides Market by Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Oligonucleotides Segment by Type
DNA Oligos
RNA Oligos
Oligonucleotides Segment by Application
Pharmaceutical
Research
Diagnostic
Oligonucleotides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oligonucleotides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Oligos
- RNA Oligos
Applications
- Pharmaceutical
- Research
- Diagnostic
Companies covered
- Integrated DNA Technologies
- Agilent
- Sigma-aldrich
- Eurofins Genomics
- L.G.C Biosearch Technologies
- Eurogentec S.A
- Nitto Denko Avecia Inc
- GenScript
- BBI Life Sciences
- GeneDesign
- TriLink BioTechnologies
- SGS DNA
- LC Sciences
- Twist Bioscience
- Creative Biogene
- General Biosystems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oligonucleotides by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Oligos
- 2.2.3 RNA Oligos
- 2.3 Oligonucleotides by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Research
- 2.3.4 Diagnostic
- 2.4 Assumptions and Limitations
3 Oligonucleotides Breakdown Data by Type
- 3.1 Global Oligonucleotides Historic Market Size by Type (2021-2026)
- 3.2 Global Oligonucleotides Forecasted Market Size by Type (2027-2032)
4 Oligonucleotides Breakdown Data by Application
- 4.1 Global Oligonucleotides Historic Market Size by Application (2021-2026)
- 4.2 Global Oligonucleotides Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oligonucleotides Market Perspective (2021-2032)
- 5.2 Global Oligonucleotides Growth Trends by Region
- 5.2.1 Global Oligonucleotides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oligonucleotides Historic Market Size by Region (2021-2026)
- 5.2.3 Oligonucleotides Forecasted Market Size by Region (2027-2032)
- 5.3 Oligonucleotides Market Dynamics
- 5.3.1 Oligonucleotides Industry Trends
- 5.3.2 Oligonucleotides Market Drivers
- 5.3.3 Oligonucleotides Market Challenges
- 5.3.4 Oligonucleotides Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oligonucleotides Players by Revenue
- 6.1.1 Global Top Oligonucleotides Players by Revenue (2021-2026)
- 6.1.2 Global Oligonucleotides Revenue Market Share by Players (2021-2026)
- 6.2 Global Oligonucleotides Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oligonucleotides Head Office and Area Served
- 6.4 Global Oligonucleotides Players, Product Type & Application
- 6.5 Global Oligonucleotides Manufacturers Established Date
- 6.6 Global Oligonucleotides Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oligonucleotides Market Size (2021-2032)
- 7.2 North America Oligonucleotides Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oligonucleotides Market Size by Country (2021-2026)
- 7.4 North America Oligonucleotides Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oligonucleotides Market Size (2021-2032)
- 8.2 Europe Oligonucleotides Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oligonucleotides Market Size by Country (2021-2026)
- 8.4 Europe Oligonucleotides Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oligonucleotides Market Size (2021-2032)
- 9.2 Asia-Pacific Oligonucleotides Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oligonucleotides Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oligonucleotides Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oligonucleotides Market Size (2021-2032)
- 10.2 South America Oligonucleotides Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oligonucleotides Market Size by Country (2021-2026)
- 10.4 South America Oligonucleotides Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oligonucleotides Market Size (2021-2032)
- 11.2 Middle East & Africa Oligonucleotides Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oligonucleotides Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oligonucleotides Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Integrated DNA Technologies
- 12.1.1 Integrated DNA Technologies Company Information
- 12.1.2 Integrated DNA Technologies Business Overview
- 12.1.3 Integrated DNA Technologies Revenue in Oligonucleotides Business (2021-2026)
- 12.1.4 Integrated DNA Technologies Oligonucleotides Product Portfolio
- 12.1.5 Integrated DNA Technologies Recent Developments
- 12.2 Agilent
- 12.2.1 Agilent Company Information
- 12.2.2 Agilent Business Overview
- 12.2.3 Agilent Revenue in Oligonucleotides Business (2021-2026)
- 12.2.4 Agilent Oligonucleotides Product Portfolio
- 12.2.5 Agilent Recent Developments
- 12.3 Sigma-aldrich
- 12.3.1 Sigma-aldrich Company Information
- 12.3.2 Sigma-aldrich Business Overview
- 12.3.3 Sigma-aldrich Revenue in Oligonucleotides Business (2021-2026)
- 12.3.4 Sigma-aldrich Oligonucleotides Product Portfolio
- 12.3.5 Sigma-aldrich Recent Developments
- 12.4 Eurofins Genomics
- 12.4.1 Eurofins Genomics Company Information
- 12.4.2 Eurofins Genomics Business Overview
- 12.4.3 Eurofins Genomics Revenue in Oligonucleotides Business (2021-2026)
- 12.4.4 Eurofins Genomics Oligonucleotides Product Portfolio
- 12.4.5 Eurofins Genomics Recent Developments
- 12.5 L.G.C Biosearch Technologies
- 12.5.1 L.G.C Biosearch Technologies Company Information
- 12.5.2 L.G.C Biosearch Technologies Business Overview
- 12.5.3 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2021-2026)
- 12.5.4 L.G.C Biosearch Technologies Oligonucleotides Product Portfolio
- 12.5.5 L.G.C Biosearch Technologies Recent Developments
- 12.6 Eurogentec S.A
- 12.6.1 Eurogentec S.A Company Information
- 12.6.2 Eurogentec S.A Business Overview
- 12.6.3 Eurogentec S.A Revenue in Oligonucleotides Business (2021-2026)
- 12.6.4 Eurogentec S.A Oligonucleotides Product Portfolio
- 12.6.5 Eurogentec S.A Recent Developments
- 12.7 Nitto Denko Avecia Inc
- 12.7.1 Nitto Denko Avecia Inc Company Information
- 12.7.2 Nitto Denko Avecia Inc Business Overview
- 12.7.3 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2021-2026)
- 12.7.4 Nitto Denko Avecia Inc Oligonucleotides Product Portfolio
- 12.7.5 Nitto Denko Avecia Inc Recent Developments
- 12.8 GenScript
- 12.8.1 GenScript Company Information
- 12.8.2 GenScript Business Overview
- 12.8.3 GenScript Revenue in Oligonucleotides Business (2021-2026)
- 12.8.4 GenScript Oligonucleotides Product Portfolio
- 12.8.5 GenScript Recent Developments
- 12.9 BBI Life Sciences
- 12.9.1 BBI Life Sciences Company Information
- 12.9.2 BBI Life Sciences Business Overview
- 12.9.3 BBI Life Sciences Revenue in Oligonucleotides Business (2021-2026)
- 12.9.4 BBI Life Sciences Oligonucleotides Product Portfolio
- 12.9.5 BBI Life Sciences Recent Developments
- 12.10 GeneDesign
- 12.10.1 GeneDesign Company Information
- 12.10.2 GeneDesign Business Overview
- 12.10.3 GeneDesign Revenue in Oligonucleotides Business (2021-2026)
- 12.10.4 GeneDesign Oligonucleotides Product Portfolio
- 12.10.5 GeneDesign Recent Developments
- 12.11 TriLink BioTechnologies
- 12.11.1 TriLink BioTechnologies Company Information
- 12.11.2 TriLink BioTechnologies Business Overview
- 12.11.3 TriLink BioTechnologies Revenue in Oligonucleotides Business (2021-2026)
- 12.11.4 TriLink BioTechnologies Oligonucleotides Product Portfolio
- 12.11.5 TriLink BioTechnologies Recent Developments
- 12.12 SGS DNA
- 12.12.1 SGS DNA Company Information
- 12.12.2 SGS DNA Business Overview
- 12.12.3 SGS DNA Revenue in Oligonucleotides Business (2021-2026)
- 12.12.4 SGS DNA Oligonucleotides Product Portfolio
- 12.12.5 SGS DNA Recent Developments
- 12.13 LC Sciences
- 12.13.1 LC Sciences Company Information
- 12.13.2 LC Sciences Business Overview
- 12.13.3 LC Sciences Revenue in Oligonucleotides Business (2021-2026)
- 12.13.4 LC Sciences Oligonucleotides Product Portfolio
- 12.13.5 LC Sciences Recent Developments
- 12.14 Twist Bioscience
- 12.14.1 Twist Bioscience Company Information
- 12.14.2 Twist Bioscience Business Overview
- 12.14.3 Twist Bioscience Revenue in Oligonucleotides Business (2021-2026)
- 12.14.4 Twist Bioscience Oligonucleotides Product Portfolio
- 12.14.5 Twist Bioscience Recent Developments
- 12.15 Creative Biogene
- 12.15.1 Creative Biogene Company Information
- 12.15.2 Creative Biogene Business Overview
- 12.15.3 Creative Biogene Revenue in Oligonucleotides Business (2021-2026)
- 12.15.4 Creative Biogene Oligonucleotides Product Portfolio
- 12.15.5 Creative Biogene Recent Developments
- 12.16 General Biosystems
- 12.16.1 General Biosystems Company Information
- 12.16.2 General Biosystems Business Overview
- 12.16.3 General Biosystems Revenue in Oligonucleotides Business (2021-2026)
- 12.16.4 General Biosystems Oligonucleotides Product Portfolio
- 12.16.5 General Biosystems Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst